PAYER POLICY CHANGES

J0578 Insurance Policy Changes

HCPCS J0578 is officially defined as "Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy." HCPCS J0578 is referenced in 5 tracked payer policy changes from Maryland Medicaid, Oregon Health Plan, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0578 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J0578

Get one email when a payer policy names J0578, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J0578

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J0578 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.